SCHEDULE 13G/AAccepted Jan 9, 8:59 AM ET
Aclaris Therapeutics, Inc. SCHEDULE 13G/A
Accepted (ET)
8:59 AM
Jan 9, 2026
Filed
Jan 9, 2026
Documents
2
Size
14.0 KB
Summary
Summary not available
This filing does not have a written summary yet. You can still open the original filing and its exhibits.